E
NeueHealth, Inc.
NEUE
$6.63
-$0.115-1.71%
E
Sell
2/28/2025Downgrade
NeueHealth, Inc. (NEUE) was downgraded to E+ from D- on 2/28/2025 due to a decline in the volatility index.
NeueHealth, Inc. (NEUE) was downgraded to E+ from D- on 2/28/2025 due to a decline in the volatility index.
D
Sell
2/13/2025Upgraded
NeueHealth, Inc. (NEUE) was upgraded to D- from E+ on 2/13/2025 due to a substantial increase in the growth index, solvency index and volatility index. EBIT increased 33.04% from -$25.9M to -$17.34M, operating cash flow increased 23.76% from -$28.43M to -$21.68M, and total revenue increased 3.07% from $225.99M to $232.93M.
NeueHealth, Inc. (NEUE) was upgraded to D- from E+ on 2/13/2025 due to a substantial increase in the growth index, solvency index and volatility index. EBIT increased 33.04% from -$25.9M to -$17.34M, operating cash flow increased 23.76% from -$28.43M to -$21.68M, and total revenue increased 3.07% from $225.99M to $232.93M.
E
Sell
1/4/2024Upgraded
Bright Health Group, Inc. (BHG) was upgraded to E+ from E on 1/4/2024 due to an increase in the volatility index and total return index.
Bright Health Group, Inc. (BHG) was upgraded to E+ from E on 1/4/2024 due to an increase in the volatility index and total return index.
E
Sell
11/24/2023Downgrade
Bright Health Group, Inc. (BHG) was downgraded to E from E+ on 11/24/2023 due to a significant decline in the solvency index, growth index and volatility index. Earnings per share declined from -$15.7002 to -$81.0276, EBIT declined 153.55% from -$22.13M to -$56.11M, and debt to equity increased from -0.7 to -0.34.
Bright Health Group, Inc. (BHG) was downgraded to E from E+ on 11/24/2023 due to a significant decline in the solvency index, growth index and volatility index. Earnings per share declined from -$15.7002 to -$81.0276, EBIT declined 153.55% from -$22.13M to -$56.11M, and debt to equity increased from -0.7 to -0.34.
E
Sell
3/14/2023Downgrade
Bright Health Group, Inc. (BHG) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index and total return index.
Bright Health Group, Inc. (BHG) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index and total return index.
D
Sell
2/23/2023Upgraded
Bright Health Group, Inc. (BHG) was upgraded to D- from E+ on 2/23/2023 due to an increase in the volatility index and total return index.
Bright Health Group, Inc. (BHG) was upgraded to D- from E+ on 2/23/2023 due to an increase in the volatility index and total return index.
E
Sell
2/8/2023Downgrade
Bright Health Group, Inc. (BHG) was downgraded to E+ from D- on 2/8/2023 due to a decline in the total return index.
Bright Health Group, Inc. (BHG) was downgraded to E+ from D- on 2/8/2023 due to a decline in the total return index.
D
Sell
1/23/2023Upgraded
Bright Health Group, Inc. (BHG) was upgraded to D- from E+ on 1/23/2023 due to an increase in the volatility index.
Bright Health Group, Inc. (BHG) was upgraded to D- from E+ on 1/23/2023 due to an increase in the volatility index.
E
Sell
1/6/2023Downgrade
Bright Health Group, Inc. (BHG) was downgraded to E+ from D- on 1/6/2023 due to a decline in the volatility index.
Bright Health Group, Inc. (BHG) was downgraded to E+ from D- on 1/6/2023 due to a decline in the volatility index.
D
Sell
8/16/2022Downgrade
Bright Health Group, Inc. (BHG) was downgraded to D- from D on 8/16/2022 due to a noticeable decline in the growth index, solvency index and volatility index. EBIT declined 50.12% from -$163.4M to -$245.29M, operating cash flow declined 50.1% from $484.76M to $241.91M, and earnings per share declined from -$0.3247 to -$0.4516.
Bright Health Group, Inc. (BHG) was downgraded to D- from D on 8/16/2022 due to a noticeable decline in the growth index, solvency index and volatility index. EBIT declined 50.12% from -$163.4M to -$245.29M, operating cash flow declined 50.1% from $484.76M to $241.91M, and earnings per share declined from -$0.3247 to -$0.4516.
D
Sell
8/12/2022Upgraded
Bright Health Group, Inc. (BHG) was upgraded to D from D- on 8/12/2022 due to an increase in the volatility index and total return index.
Bright Health Group, Inc. (BHG) was upgraded to D from D- on 8/12/2022 due to an increase in the volatility index and total return index.
D
Sell
7/26/2022Downgrade
Bright Health Group, Inc. (BHG) was downgraded to D- from D on 7/26/2022 due to a decline in the volatility index.
Bright Health Group, Inc. (BHG) was downgraded to D- from D on 7/26/2022 due to a decline in the volatility index.
D
Sell
7/8/2022Upgraded
Bright Health Group, Inc. (BHG) was upgraded to D from D- on 7/8/2022 due to an increase in the volatility index.
Bright Health Group, Inc. (BHG) was upgraded to D from D- on 7/8/2022 due to an increase in the volatility index.
D
Sell
5/31/2022Upgraded
Bright Health Group, Inc. (BHG) was upgraded to D- from E+ on 5/31/2022 due to an increase in the volatility index.
Bright Health Group, Inc. (BHG) was upgraded to D- from E+ on 5/31/2022 due to an increase in the volatility index.
E
Sell
5/13/2022Downgrade
Bright Health Group, Inc. (BHG) was downgraded to E+ from D- on 5/13/2022 due to a decline in the solvency index.
Bright Health Group, Inc. (BHG) was downgraded to E+ from D- on 5/13/2022 due to a decline in the solvency index.
D
Sell
5/5/2022Upgraded
NeueHealth, Inc. (NEUE) was upgraded to D- from E+ on 05/05/2022.
NeueHealth, Inc. (NEUE) was upgraded to D- from E+ on 05/05/2022.
E
Sell
4/20/2022Downgrade
Bright Health Group, Inc. (BHG) was downgraded to E+ from D- on 4/20/2022 due to a major decline in the efficiency index, volatility index and total return index. Net income declined 170.91% from -$300.66M to -$814.52M, and total capital declined 30.36% from $2.12B to $1.48B.
Bright Health Group, Inc. (BHG) was downgraded to E+ from D- on 4/20/2022 due to a major decline in the efficiency index, volatility index and total return index. Net income declined 170.91% from -$300.66M to -$814.52M, and total capital declined 30.36% from $2.12B to $1.48B.
D
Sell
1/12/2022Downgrade
Bright Health Group, Inc. (BHG) was downgraded to D- from D on 1/12/2022 due to a decline in the volatility index.
Bright Health Group, Inc. (BHG) was downgraded to D- from D on 1/12/2022 due to a decline in the volatility index.
D
Sell
12/28/2021Upgraded
Bright Health Group, Inc. (BHG) was upgraded to D from D- on 12/28/2021 due to an increase in the volatility index and valuation index.
Bright Health Group, Inc. (BHG) was upgraded to D from D- on 12/28/2021 due to an increase in the volatility index and valuation index.
D
Sell
11/17/2021Downgrade
Bright Health Group, Inc. (BHG) was downgraded to D- from D on 11/17/2021 due to a noticeable decline in the solvency index, growth index and efficiency index. Net income declined 575.38% from -$44.52M to -$300.66M, EBIT declined 415.76% from -$57.45M to -$296.28M, and operating cash flow declined 271.96% from $153.54M to -$264.03M.
Bright Health Group, Inc. (BHG) was downgraded to D- from D on 11/17/2021 due to a noticeable decline in the solvency index, growth index and efficiency index. Net income declined 575.38% from -$44.52M to -$300.66M, EBIT declined 415.76% from -$57.45M to -$296.28M, and operating cash flow declined 271.96% from $153.54M to -$264.03M.
D
Sell
9/17/2021None
NeueHealth, Inc. (NEUE) was downgraded to D from U on 09/17/2021.
NeueHealth, Inc. (NEUE) was downgraded to D from U on 09/17/2021.
NYSE
03/13/2025 3:39PM Eastern
Quotes delayed
